{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T14:10:29Z","timestamp":1764771029526,"version":"3.46.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,12,3]]},"DOI":"10.7759\/cureus.98373","type":"journal-article","created":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T13:47:34Z","timestamp":1764769654000},"source":"Crossref","is-referenced-by-count":0,"title":["Balancing Bleeding and Thrombosis in Dental Management of Patients on Novel Oral Anticoagulants: A Narrative Evidence Synthesis"],"prefix":"10.7759","author":[{"given":"Rama Shankar","family":"Choudhary","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nishit","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mridu","family":"Dubey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ballamudi","family":"Sarat Ravi Kiran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3390\/dj4010005","article-title":"New direct oral anticoagulants (DOAC) and their use today","volume":"4","author":"Schwarb H","year":"2016","unstructured":"Schwarb H, Tsakiris DA. New direct oral anticoagulants (DOAC) and their use today. Dent J (Basel). 2016, 4:10.3390\/dj4010005","journal-title":"Dent J (Basel)"},{"key":"ref2","article-title":"Use of direct oral anticoagulants in daily practice","volume":"8","author":"Almarshad F","year":"2018","unstructured":"Almarshad F, Alaklabi A, Bakhsh E, Pathan A, Almegren M. Use of direct oral anticoagulants in daily practice. Am J Blood Res. 2018, 8:57-72.","journal-title":"Am J Blood Res"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.16922","article-title":"Usage of direct acting oral anticoagulants in cirrhotic and non-cirrhotic portal vein thrombosis: a systematic review","volume":"13","author":"Gupta S","year":"2021","unstructured":"Gupta S, Hidalgo J, Singh B, et al.. Usage of direct acting oral anticoagulants in cirrhotic and non-cirrhotic portal vein thrombosis: a systematic review. Cureus. 2021, 13:e16922. 10.7759\/cureus.16922","journal-title":"Cureus"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-022-03652-9","article-title":"Efficacy and safety of novel oral anticoagulants in patients with atrial nonvalvular atrial fibrillation and diabetes mellitus: a systematic review and meta-analysis","volume":"20","author":"Jia X","year":"2022","unstructured":"Jia X, Yin Z, Zhang W, Du S, Kang J. Efficacy and safety of novel oral anticoagulants in patients with atrial nonvalvular atrial fibrillation and diabetes mellitus: a systematic review and meta-analysis. J Transl Med. 2022, 20:441. 10.1186\/s12967-022-03652-9","journal-title":"J Transl Med"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.2147\/TCRM.S84210","article-title":"New oral anticoagulants: their advantages and disadvantages compared with vitamin K antagonists in the prevention and treatment of patients with thromboembolic events","volume":"11","author":"Mekaj YH","year":"2015","unstructured":"Mekaj YH, Mekaj AY, Duci SB, Miftari EI. New oral anticoagulants: their advantages and disadvantages compared with vitamin K antagonists in the prevention and treatment of patients with thromboembolic events. Ther Clin Risk Manag. 2015, 11:967-77. 10.2147\/TCRM.S84210","journal-title":"Ther Clin Risk Manag"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.4317\/jced.54004","article-title":"Direct oral anticoagulants and its implications in dentistry. A review of literature","volume":"9","author":"Lanau N","year":"2017","unstructured":"Lanau N, Mareque J, Giner L, Zabalza M. Direct oral anticoagulants and its implications in dentistry. A review of literature. J Clin Exp Dent. 2017, 9:e1346-54. 10.4317\/jced.54004","journal-title":"J Clin Exp Dent"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.111.090464","article-title":"Periprocedural bleeding and thromboembolic events with dabigatran compared with warfarin: results from the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) randomized trial","volume":"126","author":"Healey JS","year":"2012","unstructured":"Healey JS, Eikelboom J, Douketis J, et al.. Periprocedural bleeding and thromboembolic events with dabigatran compared with warfarin: results from the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) randomized trial. Circulation. 2012, 126:343-8. 10.1161\/CIRCULATIONAHA.111.090464","journal-title":"Circulation"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1007\/s40256-024-00664-2","article-title":"Apixaban use in patients with kidney impairment: a review of pharmacokinetic, interventional, and observational study data","volume":"24","author":"Mandt SR","year":"2024","unstructured":"Mandt SR, Thadathil N, Klem C, Russ C, McNamee PL, Stigge K, Cheng D. Apixaban use in patients with kidney impairment: a review of pharmacokinetic, interventional, and observational study data. Am J Cardiovasc Drugs. 2024, 24:603-24. 10.1007\/s40256-024-00664-2","journal-title":"Am J Cardiovasc Drugs"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.4317\/jced.53219","article-title":"Dental management of patients taking novel oral anticoagulants (NOAs): dabigatran","volume":"9","author":"Curto A","year":"2017","unstructured":"Curto A, Albaladejo A, Alvarado A. Dental management of patients taking novel oral anticoagulants (NOAs): dabigatran. J Clin Exp Dent. 2017, 9:e289-93. 10.4317\/jced.53219","journal-title":"J Clin Exp Dent"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2025-104806","article-title":"Rationale, design and protocol for risk factors for stroke in patients with non-valvular atrial fibrillation in China: a nationwide registry (REFINE registry)","volume":"15","author":"Qi W","year":"2025","unstructured":"Qi W, Yuan S, Liu H, et al.. Rationale, design and protocol for risk factors for stroke in patients with non-valvular atrial fibrillation in China: a nationwide registry (REFINE registry). BMJ Open. 2025, 15:e104806. 10.1136\/bmjopen-2025-104806","journal-title":"BMJ Open"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1002\/clc.22435","article-title":"The HAS-BLED score for predicting major bleeding risk in anticoagulated patients with atrial fibrillation: a systematic review and meta-analysis","volume":"38","author":"Zhu W","year":"2015","unstructured":"Zhu W, He W, Guo L, Wang X, Hong K. The HAS-BLED score for predicting major bleeding risk in anticoagulated patients with atrial fibrillation: a systematic review and meta-analysis. Clin Cardiol. 2015, 38:555-61. 10.1002\/clc.22435","journal-title":"Clin Cardiol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.4317\/jced.53431","article-title":"Managing patients taking edoxaban in dentistry","volume":"9","author":"Curto A","year":"2017","unstructured":"Curto A, Curto D, Sanchez J. Managing patients taking edoxaban in dentistry. J Clin Exp Dent. 2017, 9:e308-11. 10.4317\/jced.53431","journal-title":"J Clin Exp Dent"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1007\/s00784-018-2458-2","article-title":"Bleeding related to dental treatment in patients taking novel oral anticoagulants (NOACs): a retrospective study","volume":"23","author":"Kwak EJ","year":"2019","unstructured":"Kwak EJ, Nam S, Park KM, Kim SY, Huh J, Park W. Bleeding related to dental treatment in patients taking novel oral anticoagulants (NOACs): a retrospective study. Clin Oral Investig. 2019, 23:477-84. 10.1007\/s00784-018-2458-2","journal-title":"Clin Oral Investig"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1186\/s12903-016-0278-9","article-title":"Should oral anticoagulant therapy be continued during dental extraction? A meta-analysis","volume":"16","author":"Yang S","year":"2016","unstructured":"Yang S, Shi Q, Liu J, Li J, Xu J. Should oral anticoagulant therapy be continued during dental extraction? A meta-analysis. BMC Oral Health. 2016, 16:81. 10.1186\/s12903-016-0278-9","journal-title":"BMC Oral Health"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.5125\/jkaoms.2024.50.4.189","article-title":"Post-extraction bleeding in patients on direct oral anticoagulants","volume":"50","author":"Kim MJ","year":"2024","unstructured":"Kim MJ, Kim MK, Kang SH. Post-extraction bleeding in patients on direct oral anticoagulants. J Korean Assoc Oral Maxillofac Surg. 2024, 50:189-96. 10.5125\/jkaoms.2024.50.4.189","journal-title":"J Korean Assoc Oral Maxillofac Surg"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.3390\/dj12090279","article-title":"Direct oral anticoagulants and bleeding management following tooth extractions-a prospective cohort study","volume":"12","author":"Izzetti R","year":"2024","unstructured":"Izzetti R, Cinquini C, Nisi M, Mattiozzi M, Marotta M, Barone A. Direct oral anticoagulants and bleeding management following tooth extractions-a prospective cohort study. Dent J (Basel). 2024, 12:279. 10.3390\/dj12090279","journal-title":"Dent J (Basel)"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.4317\/jced.60122","article-title":"Systematic review on the effects of the discontinuation of the anticoagulant therapy and the postoperative bleeding, in patients under new oral anticoagulants after dental extraction","volume":"15","author":"L\u00f3pez-Galindo M","year":"2023","unstructured":"L\u00f3pez-Galindo M, Grau-Ben\u00edtez M. Systematic review on the effects of the discontinuation of the anticoagulant therapy and the postoperative bleeding, in patients under new oral anticoagulants after dental extraction. J Clin Exp Dent. 2023, 15:e338-45. 10.4317\/jced.60122","journal-title":"J Clin Exp Dent"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1007\/s12630-017-0868-2","article-title":"Managing the perioperative patient on direct oral anticoagulants","volume":"64","author":"Leitch J","year":"2017","unstructured":"Leitch J, van Vlymen J. Managing the perioperative patient on direct oral anticoagulants. Can J Anaesth. 2017, 64:656-72. 10.1007\/s12630-017-0868-2","journal-title":"Can J Anaesth"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1007\/s00784-016-2010-1","article-title":"Pragmatic approach to manage new oral anticoagulants in patients undergoing dental extractions: a prospective case-control study","volume":"21","author":"Miclotte I","year":"2017","unstructured":"Miclotte I, Vanhaverbeke M, Agbaje JO, Legrand P, Vanassche T, Verhamme P, Politis C. Pragmatic approach to manage new oral anticoagulants in patients undergoing dental extractions: a prospective case-control study. Clin Oral Investig. 2017, 21:2183-8. 10.1007\/s00784-016-2010-1","journal-title":"Clin Oral Investig"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010562.pub2","article-title":"Topical application of tranexamic acid for the reduction of bleeding","volume":"2013","author":"Ker K","year":"2013","unstructured":"Ker K, Beecher D, Roberts I. Topical application of tranexamic acid for the reduction of bleeding. Cochrane Database Syst Rev. 2013, 2013:CD010562. 10.1002\/14651858.CD010562.pub2","journal-title":"Cochrane Database Syst Rev"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/j.sdentj.2022.11.007","article-title":"Gelatin-based hemostatic agents for medical and dental application at a glance: a narrative literature review","volume":"34","author":"Irfan NI","year":"2022","unstructured":"Irfan NI, Mohd Zubir AZ, Suwandi A, Haris MS, Jaswir I, Lestari W. Gelatin-based hemostatic agents for medical and dental application at a glance: a narrative literature review. Saudi Dent J. 2022, 34:699-707. 10.1016\/j.sdentj.2022.11.007","journal-title":"Saudi Dent J"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1039\/c6ra16790j","article-title":"Combination of gelatin and tranexamic acid offers improved haemostasis and safe use on internal hemorrhage control","volume":"6","author":"Aydemir Sezer U","year":"2016","unstructured":"Aydemir Sezer U, Kocer Z, Aru B, et al.. Combination of gelatin and tranexamic acid offers improved haemostasis and safe use on internal hemorrhage control. RSC Adv. 2016, 6:95189-98. 10.1039\/c6ra16790j","journal-title":"RSC Adv"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1186\/s12903-016-0170-7","article-title":"Managing patients taking novel oral anticoagulants (NOAs) in dentistry: a discussion paper on clinical implications","volume":"16","author":"Costantinides F","year":"2016","unstructured":"Costantinides F, Rizzo R, Pascazio L, Maglione M. Managing patients taking novel oral anticoagulants (NOAs) in dentistry: a discussion paper on clinical implications. BMC Oral Health. 2016, 16:5. 10.1186\/s12903-016-0170-7","journal-title":"BMC Oral Health"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.4103\/njms.NJMS_52_17","article-title":"Minimally invasive transgingival implant therapy: a literature review","volume":"9","author":"Yadav MK","year":"2018","unstructured":"Yadav MK, Verma UP, Parikh H, Dixit M. Minimally invasive transgingival implant therapy: a literature review. Natl J Maxillofac Surg. 2018, 9:117-22. 10.4103\/njms.NJMS_52_17","journal-title":"Natl J Maxillofac Surg"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1016\/j.jormas.2021.12.005","article-title":"Piezoelectric versus conventional techniques for orthognathic surgery: Systematic review and meta-analysis","volume":"123","author":"Alrefai M","year":"2022","unstructured":"Alrefai M, Daboul A, Fleischhacker B, Landes C. Piezoelectric versus conventional techniques for orthognathic surgery: Systematic review and meta-analysis. J Stomatol Oral Maxillofac Surg. 2022, 123:e273-8. 10.1016\/j.jormas.2021.12.005","journal-title":"J Stomatol Oral Maxillofac Surg"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000001685","article-title":"Piezoelectric versus conventional rotary techniques for impacted third molar extraction: a meta-analysis of randomized controlled trials","volume":"94","author":"Jiang Q","year":"2015","unstructured":"Jiang Q, Qiu Y, Yang C, Yang J, Chen M, Zhang Z. Piezoelectric versus conventional rotary techniques for impacted third molar extraction: a meta-analysis of randomized controlled trials. Medicine (Baltimore). 2015, 94:e1685. 10.1097\/MD.0000000000001685","journal-title":"Medicine (Baltimore)"},{"key":"ref27","article-title":"Diode laser application in soft tissue oral surgery","volume":"4","author":"Azma E","year":"2013","unstructured":"Azma E, Safavi N. Diode laser application in soft tissue oral surgery. J Lasers Med Sci. 2013, 4:206-11.","journal-title":"J Lasers Med Sci"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.4317\/jced.53795","article-title":"The application of diode laser in the treatment of oral soft tissues lesions. A literature review","volume":"9","author":"Ortega-Concepci\u00f3n D","year":"2017","unstructured":"Ortega-Concepci\u00f3n D, Cano-Dur\u00e1n JA, Pe\u00f1a-Cardelles JF, Paredes-Rodr\u00edguez VM, Gonz\u00e1lez-Serrano J, L\u00f3pez-Quiles J. The application of diode laser in the treatment of oral soft tissues lesions. A literature review. J Clin Exp Dent. 2017, 9:e925-8. 10.4317\/jced.53795","journal-title":"J Clin Exp Dent"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1590\/1807-3107bor-2018.vol32.0056","article-title":"Immediate laser-induced hemostasis in anticoagulated rats subjected to oral soft tissue surgery: a double-blind study","volume":"32","author":"Campos FH","year":"2018","unstructured":"Campos FH, Ferreira LB, Romano MM, Moreira MS, Eduardo CP, Ramalho KM. Immediate laser-induced hemostasis in anticoagulated rats subjected to oral soft tissue surgery: a double-blind study. Braz Oral Res. 2018, 32:e56. 10.1590\/1807-3107bor-2018.vol32.0056","journal-title":"Braz Oral Res"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehad123","article-title":"Reversal agents for current and forthcoming direct oral anticoagulants","volume":"44","author":"van Es N","year":"2023","unstructured":"van Es N, De Caterina R, Weitz JI. Reversal agents for current and forthcoming direct oral anticoagulants. Eur Heart J. 2023, 44:1795-806. 10.1093\/eurheartj\/ehad123","journal-title":"Eur Heart J"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1502000","article-title":"Idarucizumab for dabigatran reversal","volume":"373","author":"Pollack CV Jr","year":"2015","unstructured":"Pollack CV Jr, Reilly PA, Eikelboom J, et al.. Idarucizumab for dabigatran reversal. N Engl J Med. 2015, 373:511-20. 10.1056\/NEJMoa1502000","journal-title":"N Engl J Med"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1707278","article-title":"Idarucizumab for dabigatran reversal-full cohort analysis","volume":"377","author":"Pollack CV Jr","year":"2017","unstructured":"Pollack CV Jr, Reilly PA, van Ryn J, et al.. Idarucizumab for dabigatran reversal-full cohort analysis. N Engl J Med. 2017, 377:431-41. 10.1056\/NEJMoa1707278","journal-title":"N Engl J Med"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1160\/TH16-03-0224","article-title":"Single-dose ciraparantag safely and completely reverses anticoagulant effects of edoxaban","volume":"117","author":"Ansell JE","year":"2017","unstructured":"Ansell JE, Bakhru SH, Laulicht BE, et al.. Single-dose ciraparantag safely and completely reverses anticoagulant effects of edoxaban. Thromb Haemost. 2017, 117:238-45. 10.1160\/TH16-03-0224","journal-title":"Thromb Haemost"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehab637","article-title":"Ciraparantag reverses the anticoagulant activity of apixaban and rivaroxaban in healthy elderly subjects","volume":"43","author":"Ansell J","year":"2022","unstructured":"Ansell J, Bakhru S, Laulicht BE, Tracey G, Villano S, Freedman D. Ciraparantag reverses the anticoagulant activity of apixaban and rivaroxaban in healthy elderly subjects. Eur Heart J. 2022, 43:985-92. 10.1093\/eurheartj\/ehab637","journal-title":"Eur Heart J"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1007\/s12028-024-02130-y","article-title":"Efficacy and safety of andexanet Alfa versus four factor prothrombin complex concentrate for emergent reversal of factor Xa inhibitor associated intracranial hemorrhage: a systematic review and meta-analysis","volume":"42","author":"Sarhan K","year":"2025","unstructured":"Sarhan K, Mohamed RG, Elmahdi RR, et al.. Efficacy and safety of andexanet Alfa versus four factor prothrombin complex concentrate for emergent reversal of factor Xa inhibitor associated intracranial hemorrhage: a systematic review and meta-analysis. Neurocrit Care. 2025, 42:701-14. 10.1007\/s12028-024-02130-y","journal-title":"Neurocrit Care"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.3390\/pharmacy6020034","article-title":"Patient education on oral anticoagulation","volume":"6","author":"Hawes EM","year":"2018","unstructured":"Hawes EM. Patient education on oral anticoagulation. Pharmacy (Basel). 2018, 6:34. 10.3390\/pharmacy6020034","journal-title":"Pharmacy (Basel)"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1009638","article-title":"Rivaroxaban versus warfarin in nonvalvular atrial fibrillation","volume":"365","author":"Patel MR","year":"2011","unstructured":"Patel MR, Mahaffey KW, Garg J, et al.. Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. N Engl J Med. 2011, 365:883-91. 10.1056\/NEJMoa1009638","journal-title":"N Engl J Med"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1107039","article-title":"Apixaban versus warfarin in patients with atrial fibrillation","volume":"365","author":"Granger CB","year":"2011","unstructured":"Granger CB, Alexander JH, McMurray JJ, et al.. Apixaban versus warfarin in patients with atrial fibrillation. N Engl J Med. 2011, 365:981-92. 10.1056\/NEJMoa1107039","journal-title":"N Engl J Med"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1310907","article-title":"Edoxaban versus warfarin in patients with atrial fibrillation","volume":"369","author":"Giugliano RP","year":"2013","unstructured":"Giugliano RP, Ruff CT, Braunwald E, et al.. Edoxaban versus warfarin in patients with atrial fibrillation. N Engl J Med. 2013, 369:2093-104. 10.1056\/NEJMoa1310907","journal-title":"N Engl J Med"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/439980-balancing-bleeding-and-thrombosis-in-dental-management-of-patients-on-novel-oral-anticoagulants-a-narrative-evidence-synthesis","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T13:47:35Z","timestamp":1764769655000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/439980-balancing-bleeding-and-thrombosis-in-dental-management-of-patients-on-novel-oral-anticoagulants-a-narrative-evidence-synthesis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,3]]},"references-count":39,"URL":"https:\/\/doi.org\/10.7759\/cureus.98373","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12,3]]}}}